Brain Diseases and Disorders

37

[136] D. Ricard, A. Idbaih, F. Ducray, et al., “Primary brain tumours in

adults,” The Lancet, vol. 379, pp. 1984–1996, 2003.

[137] L. E. Abrey, T. T. Batchelor, A. J. M. Ferreri, et al., “Report of an

international workshop to standardize baseline evaluation and response

criteria for primary cns lymphoma.,” Journal of clinical oncology : of-

ficial journal of the American Society of Clinical Oncology, vol. 23 22,

pp. 5034–43, 2005.

[138] S. Chandana, S. Movva, M. L. Arora, et al., “Primary brain tumors in

adults.,” American family physician, vol. 77 10, pp. 1423–30, 2008.

[139] F. Hanif, K. Muzaffar, K. Perveen, et al., “Glioblastoma multiforme:

A review of its epidemiology and pathogenesis through clinical presen-

tation and treatment,” Asian Pacific Journal of Cancer Prevention:

APJCP, vol. 18, pp. 3–9, 2017.

[140] T. C. Hirst, H. M. Vesterinen, E. S. Sena, et al., “Systematic review and

meta-analysis of temozolomide in animal models of glioma: was clinical

efficacy predicted?,” British Journal of Cancer, vol. 108, pp. 64–71, 2013.

[141] N. Fathi and N. Rezaei, “Lymphopenia in covid‐19: Therapeutic oppor-

tunities,” Cell Biology International, vol. 44, pp. 1792–1797, 2020.

[142] R. Stupp, W. P. Mason, M. J. van den Bent, et al., “Radiotherapy plus

concomitant and adjuvant temozolomide for glioblastoma,” The New

England journal of medicine, vol. 352 10, pp. 987–996, 2005.

[143] F. Bernard-Arnoux, M. P. Lamure, F. Ducray, et al., “The cost-

effectiveness of tumor-treating fields therapy in patients with newly di-

agnosed glioblastoma,” Neuro-oncology, vol. 18 8, pp. 1129–1136, 2016.

[144] H. Ohgaki and P. Kleihues, “Genetic pathways to primary and secondary

glioblastoma,” The American journal of pathology, vol. 170 5, pp. 1445–

53, 2007.

[145] H. Ohgaki and P. Kleihues, “Genetic alterations and signaling pathways

in the evolution of gliomas,” Cancer Science, vol. 100, 2009.

[146] C. Krakstad and M. Chekenya, “Survival signalling and apoptosis resis-

tance in glioblastomas: opportunities for targeted therapeutics,” Molec-

ular Cancer, vol. 9, pp. 135–135, 2010.

[147] S. E.-S. Amin and M. Z. A. Megeed, “Brain tumor diagnosis systems

based on artificial neural networks and segmentation using mri,” 2012

8th International Conference on Informatics and Systems (INFOS),

pp. MM–119–MM–124, 2012.